Secondary imaging analysis of two RCTs in treatment-resistant depression: 3 days after one low-dose ketamine infusion, brain entropy rose in frontolimbic, cerebellar and neuromodulatory regions vs saline or midazolam; any link to mood benefit is unproven.
RCT
Liou et al. Low-dose ketamine modulates brain entropy in treatment-resistant depression: Results from two neuroimaging clinical trials